Skip to main content
Equibles
NXL logo

NXL · Nexalin Technology, Inc.

Track NXL — free

Use NXL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NXL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.14 -0.22 (-9.32%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has evaluated these conditions and concluded that the Company does not currently have sufficient cash and cash equivalents to fund its anticipated operating requirements for at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements. Accordingly, substantial doubt exists about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Market Cap
$1.73M
Shares
734,547
Volume · Oct 20 248.27K Avg daily vol (36 sessions) 1.82M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.14 Open$2.52 Day$2.12–2.54 52W close$0.32–7.55 Avg vol 30d2.2M Short int13K · 1.8% float · 1.0d Short vol83% DataSep 2022–Oct 2026 Filing10-Q · Aug 12

Up next

Latest filing: 10-Q
filed Aug 12, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$217,155
Trailing 12 months
Net income (TTM)
−$8.99M
Trailing 12 months
Revenue growth YoY
-82.8%
Year over year
Operating margin
-4,202.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.00M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+34.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.8%
Latest settlement · 1.0 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲49.4% $36,031 −$2.45M '24 Q3 ▲32.4% $27,179 −$2.83M '24 Q4* ▼47.9% $41,015 −$1.99M '25 Q1 ▲163% $70,588 −$1.58M '25 Q2 ▼49.6% $18,149 −$2.28M '25 Q3 ▲532.5% $171,895 −$2.38M '25 Q4* ▼63.5% $14,950 −$2.10M '26 Q1 LATEST ▼82.8% $12,161 −$2.24M '26 Q2

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +70%
above
Price vs 50-day avg −37%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 25%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Strong
1-month return −54%
trailing
6-month return +423%
trailing
YTD return +284%
this year
Relative strength +415%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $3 › 200d $1 — 50d above 200d
Institutional flow Distributing
1 of 20 funds reported for Sep 30 · net -1 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.78% of float · ▲ +4.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
20 holders — mid 3-yr range
Squeeze score 38
low risk · 0–100
Fundamentals
Excellent
Revenue growth +79%
Y/Y
Gross margin 80%
expanding
EPS growth +40%
Y/Y
Balance sheet $654.8K
net cash
Quant / Vol
risk profile
Very High
Volatility 1427%
annualized · 1-yr
Max drawdown −83%
past year
ATR 35.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+70% Bullish
Price vs 50-day avg
−37% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
25% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $3 › 200d $1 — 50d above 200d
Institutional flow Distributing
1 of 20 funds reported for Sep 30 · net -1 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.78% of float · ▲ +4.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
20 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0 Now $2 · 25% Range high $8
vs 200-day avg +70% vs 50-day avg -37%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NXL
Nexalin Technology, Inc.
this stock
$1.73M — +78.8% — 1.8%
ABT
Abbott Laboratories
 $179.20B -18.2% +5.7% 33.3 0.8%
MDT
Medtronic plc
 $118.67B -1.5% +8.4% 22.9 3.1%
SYK
Stryker Corp
 $114.28B -13.4% +11.2% 30.9 1.5%
BSX
Boston Scientific Corp
 $66.02B -52.2% +12.5% 18.4 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
20
% held
3.9%
Reported
1 of 20
Top holder
PEAK6 LLC
Held Float
View
Held by Funds
Fund positions
6
View
Short & Settlement
Short Interest Rising
Shares short
13.1K
Days to cover
1.0d
Change
+570 sh
View
Short Volume
Short vol %
83%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
42
Value
$183
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
50.7%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$301.6K
Net income (FY)
$-8.2M
EPS diluted
$-15.00
View
Filings
SEC Filings
Latest
S-1/A
Filed
Oct 8, 2026
This year
24
View
Proposed Sales
Value
$403
Shares
23.2K
Filed
Sep 10, 2025
View

Performance

5D 20D 120D MTD YTD
NXL -18.9% -53.8% +423.2% -50.0% +283.5%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -17.8% -53.2% +415.2% -50.8% +270.7%
Key facts CIK 1527352 CUSIP 65345B300 13F (30d) 2 filings 2 filers Visit website Investor relations